Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 475)
Posted On: 06/24/2022 9:08:16 AM
Post# of 154139
Posted By: MGK_2
Re: ohm20 #125313
So it's interesting that we are tracking the genetics of the patients prior to initiation of the medication. I find it interesting that in this n=72 patient trial, there were what 5 with the haplotype. That seems like a lot.

You are saying there may be even more that express increased CCR5 on the surfaces of their cells.

Possibly, we need to assess for the quantity of CCR5 surface expression and decide to give either 700 for those with higher CCR4 surface expression and give 350mg for normal CCR5 surface expression?














(1)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site